SCA1 molecular genetics: a history of a 13 year collaboration against glutamines
- PMID: 11673415
- DOI: 10.1093/hmg/10.20.2307
SCA1 molecular genetics: a history of a 13 year collaboration against glutamines
Abstract
Spinocerebellar ataxia type 1 (SCA1) is a relatively rare autosomal-dominant neurological disorder. SCA1 has the intriguing feature that the disease-causing mutation is the expansion of an unstable trinucleotide repeat, specifically a CAG repeat that encodes the amino acid glutamine in ataxin-1. During the past 10 years, substantial progress has been made towards understanding the pathogenic mechanism in this disease. The nucleus has been identified as the subcellular site where the mutant protein acts to cause disease. Evidence indicates that expansion of the glutamine tract alters the folding properties of ataxin-1. Finally, several cellular pathways have been identified which are able to impinge on the SCA1 disease process. The characterization of these pathways and their role in SCA1 will guide research over the next several years.
Similar articles
-
Progress in pathogenesis studies of spinocerebellar ataxia type 1.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.
-
Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.Arch Neurol. 2004 May;61(5):727-33. doi: 10.1001/archneur.61.5.727. Arch Neurol. 2004. PMID: 15148151
-
Antisense RNA sequences modulating the ataxin-1 message: molecular model of gene therapy for spinocerebellar ataxia type 1, a dominant-acting unstable trinucleotide repeat disease.Cell Transplant. 2008;17(7):723-34. doi: 10.3727/096368908786516729. Cell Transplant. 2008. PMID: 19044200
-
Cell biology of spinocerebellar ataxia.J Cell Biol. 2012 Apr 16;197(2):167-77. doi: 10.1083/jcb.201105092. J Cell Biol. 2012. PMID: 22508507 Free PMC article. Review.
-
No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3.Psychiatr Genet. 2004 Jun;14(2):61-3. doi: 10.1097/01.ypg.0000128763.69225.77. Psychiatr Genet. 2004. PMID: 15167689
Cited by
-
dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1.PLoS Genet. 2007 Dec 28;3(12):e234. doi: 10.1371/journal.pgen.0030234. Epub 2007 Nov 16. PLoS Genet. 2007. PMID: 18166084 Free PMC article.
-
Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.Exp Neurol. 2007 Feb;203(2):531-41. doi: 10.1016/j.expneurol.2006.09.009. Epub 2006 Nov 9. Exp Neurol. 2007. PMID: 17097639 Free PMC article.
-
Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.J Neurosci. 2015 Aug 12;35(32):11292-307. doi: 10.1523/JNEUROSCI.1357-15.2015. J Neurosci. 2015. PMID: 26269637 Free PMC article.
-
Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.PLoS Med. 2007 May;4(5):e182. doi: 10.1371/journal.pmed.0040182. PLoS Med. 2007. PMID: 17535104 Free PMC article.
-
Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome.J Investig Med. 2009 Dec;57(8):825-9. doi: 10.2310/JIM.0b013e3181be329a. J Investig Med. 2009. PMID: 19794313 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous